ELAN - Company ID 0001739104
The table below shows Elanco Animal Health Inc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.37B | $1.14B | $1.24B | $1.19B | $1.03B | $1.18B |
| Cost of revenue | $586.00M | $530.00M | $528.00M | $509.00M | $492.00M | $495.00M |
| Gross profit | $785.00M | $607.00M | $713.00M | $684.00M | $538.00M | $689.00M |
| R&D | $97.00M | $89.00M | $92.00M | $94.00M | $87.00M | $89.00M |
Elanco Animal Health Inc reported annual revenue of $4.71B for fiscal year 2025. That is up 6.2% from $4.44B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.91B (FY 2016) to $4.71B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $381.00M | $351.00M | $400.00M | $341.00M | $323.00M | $354.00M |
| Operating income | - | - | - | - | - | - |
| Income tax | $30.00M | -$16.00M | $14.00M | -$7.00M | $195.00M | $18.00M |
| Net income | $57.00M | -$34.00M | $11.00M | $67.00M | $364.00M | -$50.00M |
| EPS (diluted) | $0.11 | -$0.07 | $0.02 | $0.13 | $0.73 | -$0.10 |